ArticleJournal of neuroinflammation2026
St6gal1-mediated sialylation protects retinal ganglion cells by restraining microglial phagocytosis.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The death of retinal ganglion cells (RGCs) is a pivotal pathological event that leads to irreversible vision loss following optic nerve injury. RGCs display substantial heterogeneity, with distinct subtypes exhibiting variable resilience to injury, but the mechanisms underlying the intrinsic survival advantage remain to be defined. Here, by analyzing mouse RGC single-cell RNA sequencing datasets, we found that αRGCs expressed markedly higher levels of sialyltransferases, particularly ST6Gal1. In the mouse optic nerve crush (ONC) model, we confirmed that blockade of sialylation significantly reduced αRGC survival. Conversely, overexpression of ST6Gal1 enhanced the survival of intrinsically photosensitive RGCs and other RGCs after ONC, and conferred broad neuroprotection in additional in vivo mouse retinal injury models including I/R and NMDA excitotoxicity. Notably, overexpressing ST6TGal1 promoted optic nerve axon regeneration independent of mTOR signaling activation. Mechanistically, single-cell transcriptomic profiling revealed that ST6Gal1-mediated sialylation potentially facilitated the transition of microglia toward a homeostatic state after injury, thereby attenuating phagocytic clearance of RGCs. Together, these findings uncover a previously unrecognized sialylation-mediated regulatory axis that promotes RGC survival and optic nerve regeneration, offering a neuron-directed strategy to mitigate microglia-driven neurodegeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.